Sciencast Management LP Takes Position in Danaher Corporation $DHR

Sciencast Management LP bought a new stake in Danaher Corporation (NYSE:DHR) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,000 shares of the conglomerate’s stock, valued at approximately $205,000.

A number of other institutional investors have also added to or reduced their stakes in DHR. Bank Pictet & Cie Europe AG increased its position in Danaher by 22.8% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate’s stock worth $44,241,000 after purchasing an additional 35,730 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Danaher by 7.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 63,534 shares of the conglomerate’s stock worth $14,584,000 after purchasing an additional 4,388 shares in the last quarter. Minot DeBlois Advisors LLC acquired a new position in Danaher during the 4th quarter worth approximately $1,606,000. Obermeyer Wealth Partners increased its position in Danaher by 25.6% during the 4th quarter. Obermeyer Wealth Partners now owns 2,012 shares of the conglomerate’s stock worth $462,000 after purchasing an additional 410 shares in the last quarter. Finally, OMERS ADMINISTRATION Corp increased its position in Danaher by 74.3% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 50,202 shares of the conglomerate’s stock worth $11,524,000 after purchasing an additional 21,397 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on DHR. Barclays reiterated an “overweight” rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Guggenheim restated a “buy” rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, July 23rd. Wells Fargo & Company decreased their price target on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 23rd. UBS Group decreased their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research report on Wednesday, July 23rd. Finally, Evercore ISI decreased their price target on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a research report on Tuesday, July 8th. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $246.35.

Insider Transactions at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.20% of the stock is currently owned by corporate insiders.

Danaher Trading Down 2.2%

NYSE:DHR opened at $194.24 on Wednesday. The firm’s fifty day moving average is $201.82 and its 200-day moving average is $199.20. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.90. The firm has a market cap of $139.09 billion, a P/E ratio of 41.33, a P/E/G ratio of 2.77 and a beta of 0.75.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period in the prior year, the firm posted $1.72 EPS. The company’s quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s dividend payout ratio is currently 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.